CiteFacts · FDA Drug Shortages · FDA source
Streptozocin Powder, For Solution
Status
FDA currently lists this ingredient in shortage.
This is nationwide FDA status, not local pharmacy inventory. CiteFacts does not provide medical, treatment, substitution, or dosing advice.
FDA package and manufacturer records
| Company | Presentation | FDA availability field | FDA update |
|---|---|---|---|
| ESTEVE PHARMACEUTICALS, S.A. | Zanosar, Powder, For Solution, 1 g/10 mL (NDC 68118-100-01) | Available | 05/06/2026 |
| Teva Pharmaceuticals USA, Inc. | Zanosar, Powder, For Solution, 100 mg/1 mL (NDC 0703-4636-01) | Unavailable | 08/17/2026 |
Source facts
Grouped generic ingredient: Streptozocin Powder, For Solution · 2 package records · Latest FDA row update: 08/17/2026
Therapeutic categories: Oncology
Dosage forms: Powder, For Solution
Routes: INTRAVENOUS
Open FDA source data · JSON · Markdown
FDA is authoritative. Source retrieved 2026-08-22T15:54:11+00:00. Derived grouping is documented in this record's derivations.